Cargando…
Refining the concept of GFAP toxicity in Alexander disease
BACKGROUND: Alexander disease is caused by dominantly acting mutations in glial fibrillary acidic protein (GFAP), the major intermediate filament of astrocytes in the central nervous system. MAIN BODY: In addition to the sequence variants that represent the origin of disease, GFAP accumulation also...
Autor principal: | Messing, Albee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913036/ https://www.ncbi.nlm.nih.gov/pubmed/31838996 http://dx.doi.org/10.1186/s11689-019-9290-0 |
Ejemplares similares
-
GFAP expression as an indicator of disease severity in mouse models of Alexander disease
por: Jany, Paige L., et al.
Publicado: (2013) -
CSF and Blood Levels of GFAP in Alexander Disease
por: Jany, Paige L., et al.
Publicado: (2015) -
STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander Disease
por: Hagemann, Tracy L., et al.
Publicado: (2023) -
Regulation of GFAP Expression
por: Brenner, Michael, et al.
Publicado: (2021) -
GFAP at 50
por: Messing, Albee, et al.
Publicado: (2020)